New cervical cancer treatment approach could reduce risk of death by 40%, trial results show
Fox News
A UK trial found that a new approach to administering chemotherapy to cervical cancer patients improved survival risk. Researcher Dr. McCormack and oncologist Dr. Slomovitz react to the findings.
Angelica Stabile is a lifestyle reporter for Fox News Digital.
In a phase 3 trial, patients went through a short, six-week course of chemotherapy before starting standard chemoradiation (CRT) treatment.
More Related News